Statistics for Pulmonx (id:8007 LUNG)

Valuation metrics

Market cap

250.35M

Enterprise value

198.38M

Trailing P/E (ttm)

-3.87

Forward P/E

-3.96

PEG ratio

-3.96

Price/Sales (ttm)

3.16

Price/Book (mrq)

2.66

Enterprise Value/Revenue

2.50

Enterprise Value/EBITDA

-3.61

Overview

Shares outstanding

39.49M

Float

37.82M

Shares short

986.14K

% Held by insiders

0.05%

% Held by institutions

0.95%

Average volume (10 days)

239.43K

Average volume (90 days)

Price summary

52-Week low

5.46

52-Week high

14.84

52-Week change

-78.23%

Beta

0.68

50-Day moving average

7.22

200-Day moving average

8.04

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-72.01%

Operating margin

-69.30%

Operational effectiveness

Return on assets

-20.04%

Return on equity

-51.99%

Income statement

Revenue (ttm)

2.04

Revenue per share (ttm)

2.04

Quarterly revenue growth (yoy)

Gross profit (ttm)

50.75M

EBITDA

-55,003,000.00

Net income to common (ttm)

-57,107,000.00

Diluted EPS (ttm)

-1.47

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

107.78M

Total cash per share (mrq)

2.73

Total debt (mrq)

55.81M

Total Debt/Equity (mrq)

59.42

Current ratio (mrq)

770.10%

Book value per share (mrq)

2.38

Cash flow

Cash flow statement

-33,256,000.00

Levered free cash flow (LFCF)

-14,473,875.00